Literature DB >> 22842724

Evaluation of antibodies directed against human protease-activated receptor-2.

Mark N Adams1, Charles N Pagel, Eleanor J Mackie, John D Hooper.   

Abstract

Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor activated by intramolecular docking of a tethered ligand that is released by the actions of proteases, mainly of the serine protease family. Here, we evaluate four commercially available anti-PAR2 antibodies, SAM11, C17, N19 and H99, demonstrating marked differences in the ability of these reagents to detect the target receptor in Western blot, immunocytochemical and flow cytometry applications. In Western blot analysis, we evaluated antibody reactivity against both ectopic and endogenous receptors. Against material from transfected cells, we show that SAM11 and N19, and to a lesser extent C17, but not H99, are able to detect ectopic PAR2. Interestingly, these Western blot analyses indicate that N19 and C17 detect conformations of ectopic PAR2 distinct to those recognised by SAM11. Significantly, our data also indicate that Western blot signal detected by SAM11 and C17, and much of the signal detected by N19, against cells endogenously expressing PAR2 is non-specific. Despite confounding non-specific signals, we were able to discern N19 reactivity against endogenous PAR2 as a broad smear that we also observed in ectopically expressing human and mouse cells and that is sensitive to loss of N-glycosylation. In immunocytochemistry analysis, each antibody is able to detect ectopic PAR2 although it appears that H99 detects only a subset of the ectopically expressed receptor. In addition, SAM11 and N19 are able to detect both ectopic and endogenous cell surface PAR2 by flow cytometry. In summary: (1) each antibody can detect ectopic PAR2 by immunocytochemical analysis with SAM11 and N19 suitable for cell surface detection of both ectopic and endogenous receptor by flow cytometry; (2) in Western blot analysis, N19, SAM11 and C17 can detect ectopically expressed PAR2, with only N19 able to detect the endogenous receptor by this technique and (3) in each of these approaches, appropriate controls are essential to ensure that non-specific reactivity is identified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842724     DOI: 10.1007/s00210-012-0783-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

1.  Mucosal allergic sensitization to cockroach allergens is dependent on proteinase activity and proteinase-activated receptor-2 activation.

Authors:  Narcy G Arizmendi; Melanie Abel; Koichiro Mihara; Courtney Davidson; Danny Polley; Ahmed Nadeem; Tamer El Mays; Brendan F Gilmore; Brian Walker; John R Gordon; Morley D Hollenberg; Harissios Vliagoftis
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

3.  Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2.

Authors:  Naoko Asano-Kato; Kazumi Fukagawa; Naoko Okada; Murat Dogru; Kazuo Tsubota; Hiroshi Fujishima
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

4.  Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

Authors:  Jörg Buddenkotte; Christopher Stroh; Ingo H Engels; Corinna Moormann; Victoria M Shpacovitch; Stephan Seeliger; Nathalie Vergnolle; Dietmar Vestweber; Thomas A Luger; Klaus Schulze-Osthoff; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

5.  Proteinase-activated receptors, targets for kallikrein signaling.

Authors:  Katerina Oikonomopoulou; Kristina K Hansen; Mahmoud Saifeddine; Illa Tea; Michael Blaber; Sachiko I Blaber; Isobel Scarisbrick; Patricia Andrade-Gordon; Graeme S Cottrell; Nigel W Bunnett; Eleftherios P Diamandis; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2006-08-02       Impact factor: 5.157

6.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.

Authors:  Yaowu He; Andreas Wortmann; Les J Burke; Janet C Reid; Mark N Adams; Ibtissam Abdul-Jabbar; James P Quigley; Richard Leduc; Daniel Kirchhofer; John D Hooper
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

8.  Antagonism of protease-activated receptor 2 protects against experimental colitis.

Authors:  Rink-Jan Lohman; Adam J Cotterell; Jacky Suen; Ligong Liu; Anh T Do; David A Vesey; David P Fairlie
Journal:  J Pharmacol Exp Ther       Date:  2011-10-25       Impact factor: 4.030

9.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

Review 10.  The cell surface glycoprotein CDCP1 in cancer--insights, opportunities, and challenges.

Authors:  Andreas Wortmann; Yaowu He; Elena I Deryugina; James P Quigley; John D Hooper
Journal:  IUBMB Life       Date:  2009-07       Impact factor: 3.885

View more
  14 in total

1.  Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Authors:  Franck Talmont; Lionel Moulédous
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-24       Impact factor: 3.000

2.  Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells.

Authors:  Vadim Iablokov; Christina L Hirota; Michael A Peplowski; Rithwik Ramachandran; Koichiro Mihara; Morley D Hollenberg; Wallace K MacNaughton
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

3.  Lack of specificity shown by P2Y6 receptor antibodies.

Authors:  Weiqun Yu; Warren G Hill
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-22       Impact factor: 3.000

4.  Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.

Authors:  Kathryn H Driesbaugh; Marguerite S Buzza; Erik W Martin; Gregory D Conway; Joseph P Y Kao; Toni M Antalis
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

5.  Rat β₃-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues.

Authors:  Hana Cernecka; Wisuit Pradidarcheep; Wouter H Lamers; Martina Schmidt; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

Review 6.  Cofactoring and dimerization of proteinase-activated receptors.

Authors:  Huilan Lin; Allen P Liu; Thomas H Smith; JoAnn Trejo
Journal:  Pharmacol Rev       Date:  2013-09-24       Impact factor: 25.468

7.  PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by Pseudomonas aeruginosa.

Authors:  Derek B McMahon; Ryan M Carey; Michael A Kohanski; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-03       Impact factor: 5.464

8.  Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice.

Authors:  John C Hennessey; John J McGuire
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

9.  Expression of protease-activated receptor 1 and 2 and anti-tubulogenic activity of protease-activated receptor 1 in human endothelial colony-forming cells.

Authors:  Tiago M Fortunato; Dina S Vara; Caroline P Wheeler-Jones; Giordano Pula
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 10.  Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.

Authors:  Satomi Kagota; Kana Maruyama; John J McGuire
Journal:  Biomed Res Int       Date:  2016-02-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.